GlassScriptPhysician profile
Mallory Washington
NPI 1912567447
$605.78
in general payments reported to CMS, 2019-2025
12 companies · $180 in 2025
The $180 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.67 · 2023: $19.20 · 2024: $372 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $571.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $181.79 | 2024-2025 | Azstarys |
| Collegium Pharmaceutical, INC. | $86.33 | 2025 | Jornay Pm |
| Ironshore Pharmaceuticals INC. | $77.03 | 2024 | |
| Cranial Technologies, INC | $40.44 | 2024-2025 | Doc Band |
| Seqirus USA INC | $38.99 | 2024-2025 | Flucelvax |
| Kaleo, INC. | $36.35 | 2021-2024 | Auvi-Q |
| Sanofi-Aventis U.S. LLC | $34.18 | 2024 | |
| Verrica Pharmaceuticals INC. | $34.05 | 2024-2025 | Ycanth |
| Glaxosmithkline, LLC. | $21.50 | 2024 | Bexsero |
| Supernus Pharmaceuticals, INC. | $19.20 | 2023 | Qelbree |
| Eyevance Pharmaceuticals LLC | $18.00 | 2021 | |
| Merck Sharp & Dohme LLC | $17.92 | 2024 | Gardasil 9, Vaxelis, Gardasil |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Washington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.